Breastfeeding and maternal bone health 10 years postpartum: findings from the ROLO longitudinal cohort study
Saoirse Kennedy1,2, Kristyn Dunlop2, Sophie Callanan2
1St Vincent's University Hospital, Dublin, Ireland.
Abstract:
Brief rationale: To investigate associations between breastfeeding behaviours and maternal bone health at 10-year follow-up.
Main Result:
Breastfeeding durations were not associated with DXA measurements. Significance of the paper: These findings add to the evidence that breastfeeding is not associated with adverse long-term maternal bone health.
Purpose:
To investigate associations between breastfeeding behaviours and dual-energy X-ray absorptiometry (DXA) measurements of maternal bone health at 10-year follow-up. Associations with bone turnover markers (BTMs) were examined as exploratory secondary outcomes.
Methods:
This was an analysis of 196 women from the ROLO (Randomised cOntrol trial of a LOw glycaemic index diet in pregnancy to prevent macrosomia) longitudinal cohort study at 10-year follow-up. Data on demographics, lifestyle and breastfeeding were collected by questionnaire. DXA measurements were available for 171 participants and BTM measurements for 60. Exclusive breastfeeding duration, any breastfeeding duration and three mutually exclusive cumulative breastfeeding groups (never breastfed, breastfed for <12 months, and breastfed for ≥12 months) were each examined in relation to bone health outcomes.
Results:
The mean (SD) age of participants was 42.8 (3.87) years and 97.9% were premenopausal. Ever breastfeeding rates were 70.9% (n = 139/196) and 40.3% (n = 79/196) had a cumulative breastfeeding duration of ≥12 months. Breastfeeding durations were not associated with DXA measurements at 10-year follow-up. An unadjusted difference in β-CTX-I was observed between the ≥12-month and never-breastfed groups (p = 0.038) however, given the small group size an adjusted analysis was underpowered.
Conclusion:
These findings reassure women that breastfeeding does not have a lasting negative impact on skeletal health. The exploratory BTM finding should be interpreted cautiously.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
